Novo Nordisk Gets Hemophilia Boost as CagriSema Device Pause Stays in the Background
Novo Nordisk shares are staging a recovery from March’s 52-week trough, supported by encouraging late-stage hemophilia data and…
European Lithium Faces a A$24 Million Gap and Greenland Permit Pause as Merger Clock Ticks
European Lithium faces a A$24 million liquidity shortfall and pending Greenland pilot plant permit as it races to…